National Penn Investors Trust’s Bristol-Myers Squibb BMY Stock Holding History

National Penn Investors Trust’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$912K	Sell	14,267 -651	-4%	-$41.1K	0.11%	118
2015 Q4	$1.03M	Sell	14,918 -65	-0.4%	-$4.29K	0.12%	117
2015 Q3	$887K	Hold	14,983	–	–	0.1%	119
2015 Q2	$997K	Sell	14,983 -832	-5%	-$54.8K	0.11%	116
2015 Q1	$1.02M	Sell	15,815 -676	-4%	-$42.3K	0.11%	116
2014 Q4	$974K	Buy	16,491 +761	+5%	+$42.9K	0.11%	111
2014 Q3	$805K	Sell	15,730 -2,600	-14%	-$130K	0.1%	116
2014 Q2	$889K	Sell	18,330 -570	-3%	-$28.1K	0.1%	113
2014 Q1	$982K	Sell	18,900 -3,245	-15%	-$173K	0.12%	111
2013 Q4	$1.18M	Buy	22,145 +3,021	+16%	+$154K	0.13%	112
2013 Q3	$885K	Sell	19,124 -394	-2%	-$17.3K	0.11%	116
2013 Q2	$872K	Buy	+19,518	New	+$847K	0.11%	120

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

National Penn Investors Trust's BMY Position: Q1 2016 in Review

National Penn Investors Trust reduced its Bristol-Myers Squibb (BMY) stake by 4.4% in Q1 2016, selling an estimated $41.1K and leaving 14,267 shares worth $912K. The position accounts for 0.11% of the portfolio, ranked #118.

National Penn Investors Trust first reported a position in BMY in Q2 2013 and has held it in 12 quarters since. The position peaked at $1.18M in Q4 2013. 1,524 funds tracked by Wall St. Rank hold BMY as of Q1 2016.

National Penn Investors Trust held 14,267 shares of Bristol-Myers Squibb worth $912K as of Q1 2016.
National Penn Investors Trust sold 651 Bristol-Myers Squibb shares in Q1 2016, an estimated $41.1K.
Bristol-Myers Squibb made up 0.11% of National Penn Investors Trust's portfolio in Q1 2016, its #118 holding.
National Penn Investors Trust first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 12 quarters since.
National Penn Investors Trust's Bristol-Myers Squibb position peaked at $1.18M in Q4 2013.
1,524 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2016.

Based on National Penn Investors Trust's 13F filing for Q1 2016, filed 11 May 2016.